{"schema_version":"secwatch.filing_event.v1","accession":"0001380106-26-000045","form_type":"8-K","ticker":"RPID","cik":"0001380106","company_name":"RAPID MICRO BIOSYSTEMS, INC.","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.952409+00:00","generated_at":"2026-05-15T08:34:56.035597+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"COO John Wilson departs April 10; CEO Spignesi assumes operating role","bullets":["John Wilson, COO, will leave as of April 10, 2026 for family reasons; no disagreement with the Company.","CEO Robert Spignesi will also serve as principal operating officer effective April 10, 2026.","Separation agreement includes consulting at $200/hr, max 20 hrs/month through June 30, 2026.","Vested stock option exercise period extended to March 31, 2027, with weekly sale cap of 20,000 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001380106-26-000045","json":"https://secwatch.observer/filing/0001380106-26-000045.json","markdown":"https://secwatch.observer/filing/0001380106-26-000045.md","text":"https://secwatch.observer/filing/0001380106-26-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000045/0001380106-26-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000045/rpid-20260323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:34:56.035597+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}